Library / regulatory-reference
Sudan: National Medicines and Poisons Board (NMPB)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The National Medicines and Poisons Board, known by its initials NMPB, is Sudan's national regulator for medicines and poisons, operating under the Federal Ministry of Health.
Sudan depends heavily on imported medicines and on humanitarian supply channels, so the board's registration and import-control decisions are central to the country's medicine availability.
How products enter the market
Medicines require registration after evaluation of quality and supporting documentation, and importers, wholesalers and pharmacies are licensed by the board.
Post-market work includes quality-control testing through the board's laboratory functions and safety monitoring, alongside control of narcotics and poisons under its statutory mandate.
Regional and international role
The board works with international and regional partners on quality assurance of humanitarian medicines supplies, an outsized part of Sudan's medicine flow.
Its experience regulating under resource constraints is a reference point for medicines oversight in fragile settings.
Using this profile
The board publishes announcements and regulatory information in Arabic through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: the NMPB illustrates the import-dependent regulator with a dual medicines-and-poisons mandate, where humanitarian supply chains carry unusual weight.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.